These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 16148111)

  • 1. Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse.
    Singh R; Dominiecki ME; Jaffee EM; Paterson Y
    J Immunol; 2005 Sep; 175(6):3663-73. PubMed ID: 16148111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancer.
    Singh R; Paterson Y
    Cancer Res; 2006 Aug; 66(15):7748-57. PubMed ID: 16885378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.
    Gunn GR; Zubair A; Peters C; Pan ZK; Wu TC; Paterson Y
    J Immunol; 2001 Dec; 167(11):6471-9. PubMed ID: 11714814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model.
    Seavey MM; Maciag PC; Al-Rawi N; Sewell D; Paterson Y
    J Immunol; 2009 May; 182(9):5537-46. PubMed ID: 19380802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action.
    Kim SH; Castro F; Paterson Y; Gravekamp C
    Cancer Res; 2009 Jul; 69(14):5860-6. PubMed ID: 19584282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.
    Sewell DA; Shahabi V; Gunn GR; Pan ZK; Dominiecki ME; Paterson Y
    Cancer Res; 2004 Dec; 64(24):8821-5. PubMed ID: 15604239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoediting sculpts tumor epitopes during immunotherapy.
    Singh R; Paterson Y
    Cancer Res; 2007 Mar; 67(5):1887-92. PubMed ID: 17332314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O.
    Cornell KA; Bouwer HG; Hinrichs DJ; Barry RA
    J Immunol; 1999 Jul; 163(1):322-9. PubMed ID: 10384131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Listeriolysin O-deficient Listeria monocytogenes as a vaccine delivery vehicle: antigen-specific CD8 T cell priming and protective immunity.
    Hamilton SE; Badovinac VP; Khanolkar A; Harty JT
    J Immunol; 2006 Sep; 177(6):4012-20. PubMed ID: 16951364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors.
    Seavey MM; Pan ZK; Maciag PC; Wallecha A; Rivera S; Paterson Y; Shahabi V
    Clin Cancer Res; 2009 Feb; 15(3):924-32. PubMed ID: 19188163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella.
    Verma NK; Ziegler HK; Wilson M; Khan M; Safley S; Stocker BA; Schoolnik GK
    Vaccine; 1995 Feb; 13(2):142-50. PubMed ID: 7625107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases.
    Kim SH; Castro F; Gonzalez D; Maciag PC; Paterson Y; Gravekamp C
    Br J Cancer; 2008 Sep; 99(5):741-9. PubMed ID: 18728665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal vaccine using CTL epitope-pulsed dendritic cell confers protection for intracellular pathogen.
    Ozawa Y; Suda T; Nagata T; Hashimoto D; Nakamura Y; Enomoto N; Inui N; Koide Y; Nakamura H; Chida K
    Am J Respir Cell Mol Biol; 2009 Oct; 41(4):440-8. PubMed ID: 19202004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes-based vaccines.
    Singh R; Paterson Y
    Cancer Immunol Immunother; 2007 Jun; 56(6):927-38. PubMed ID: 17131121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus anthracis induces CD8-mediated protection against Listeria monocytogenes.
    Sirard JC; Fayolle C; de Chastellier C; Mock M; Leclerc C; Berche P
    J Immunol; 1997 Nov; 159(9):4435-43. PubMed ID: 9379042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of listeriolysin-O (LLO) in the T lymphocyte response to infection with Listeria monocytogenes. Identification of T cell epitopes of LLO.
    Safley SA; Cluff CW; Marshall NE; Ziegler HK
    J Immunol; 1991 May; 146(10):3604-16. PubMed ID: 1709197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Episomal expression of truncated listeriolysin O in LmddA-LLO-E7 vaccine enhances antitumor efficacy by preferentially inducing expansions of CD4+FoxP3- and CD8+ T cells.
    Chen Z; Ozbun L; Chong N; Wallecha A; Berzofsky JA; Khleif SN
    Cancer Immunol Res; 2014 Sep; 2(9):911-22. PubMed ID: 24872025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Listeria monocytogenes based vaccine against prostate cancer.
    Shahabi V; Reyes-Reyes M; Wallecha A; Rivera S; Paterson Y; Maciag P
    Cancer Immunol Immunother; 2008 Sep; 57(9):1301-13. PubMed ID: 18273616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8(+) T cells against Listeria monocytogenes in the murine infection model.
    Bahey-El-Din M; Casey PG; Griffin BT; Gahan CG
    Vaccine; 2008 Sep; 26(41):5304-14. PubMed ID: 18691625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human.
    Shahabi V; Seavey MM; Maciag PC; Rivera S; Wallecha A
    Cancer Gene Ther; 2011 Jan; 18(1):53-62. PubMed ID: 20725099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.